R

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Associate Director Quantitative Pharmacology

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-time$176.1k - $287.3k /yr

About the Job

Requirements

  • A PhD in Quantitative Pharmacology, Pharmacometrics, Engineering, or a related field with at least 7 years of post-doctoral or industry experience, or an MS with at least 9 years of relevant experience.
  • Demonstrated expertise in population pharmacokinetics/pharmacodynamics, exposure–response, or mechanistic modeling (systems biology or quantitative systems pharmacology) using tools such as NONMEM, Monolix, Simulx, MATLAB/Simbiology, and R.
  • A proven track record of delivering analyses supporting regulatory submissions and engaging directly with agencies such as the FDA, EMA, or PMDA.
  • Hands-on experience with a broad range of quantitative and computational tools and a strong publication record.
  • Ability to communicate and partner effectively across technical and non-technical teams.

Responsibilities

  • Lead model-informed drug development strategies supporting one or more therapeutic areas across modalities including antibodies, siRNA, and gene therapies to inform dose selection, trial design, and regulatory strategy from early development through submission.
  • Proactively identify and provide significant, potentially complex pharmacometrics contributions for research and development programs addressing strategically important needs, scientific advancements, or significant regulatory hurdles.
  • Contribute to overall strategic program development and communicate complex pharmacometrics strategies and results influentially to the development team.
  • Independently design and conduct, or otherwise oversee development of, pharmacometrics analysis plans and apply standardized or advanced scientific techniques to conduct pharmacokinetic, pharmacodynamic, and other quantitative analyses.
  • Prepare and timely deliver accurate, well-articulated nonclinical or clinical study reports and regulatory submission documents as appropriate.

About the Company

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Regeneron Pharmaceuticals develops and commercializes medicines for serious diseases, with a focus on cancer, eye diseases, allergic and inflammatory diseases, and infectious diseases. Its products come from using proprietary research capabilities and technologies to discover and develop therapies, often in collaboration with academic, research, and industry partners. Revenue comes from selling approved medicines and from licensing its technologies and entering co-development and co-commercialization partnerships. The company works with healthcare providers and regulators to ensure treatment delivery and safety. Its goal is to improve patient outcomes by bringing life-transforming medicines to market through rigorous R&D and strategic collaborations, maintaining leadership in biopharmaceutical innovation.

Company size
10,001+
Company stage
IPO
Headquarters
Town of Mount Pleasant, New York
Founded
1988

Recently Posted Jobs

Explore more opportunities at Regeneron Pharmaceuticals

See more jobs